Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: The Insight Partners | PRODUCT CODE: 1494291

Cover Image

PUBLISHER: The Insight Partners | PRODUCT CODE: 1494291

South & Central America Coagulation Market Forecast to 2030 - Regional Analysis - by Disease Indications, Type, Offering, Technology, and End User

PUBLISHED:
PAGES: 95 Pages
DELIVERY TIME: 1-5 business days
SELECT AN OPTION
PDF (Single User License)
USD 3450
PDF (Site License)
USD 4450
PDF (Enterprise License)
USD 5450

Add to Cart

The South & Central America coagulation market was valued at US$ 401.01 million in 2022 and is expected to reach US$ 700.04 million by 2030; it is estimated to grow at a CAGR of 7.2% from 2022 to 2030.

Growing Organic and Inorganic Strategies by Key Market Players Fuel South & Central America Coagulation Market

Changing lifestyle habits and a growing geriatric population are among the major factors increasing the prevalence of blood disorders. Therefore, there is a growing demand for early diagnosis and treatment. Key players are taking several initiatives through various organic and inorganic strategies to enhance the quality of life of patient population.

  • In June 2021, Trivitron Healthcare introduced NANO H5 and NANO H110, which help in monitoring diabetes, hemoglobin variations, and thalassemia.
  • In February 2021, Siemens Healthineers and Sysmex Corporation renewed their agreement to supply, distribute, sell, and service hemostasis products across the world. The agreement also included an extension for multiple years. Further, Siemens Healthineers agreed to distribute Sysmex's automated blood coagulation analyzer, such as the CN-3000 and CN-6000.
  • In July 2022, HORIBA Medical launched the latest Yumizen G800 and G1550 hemostasis analyzers, as well as a range of convenient ready-to-use reagents for common blood coagulation Offerings. With this expansion of its product line, HORIBA Medical now offers a comprehensive selection of hemostasis systems and advanced reagents for laboratories of all sizes and requirements.

Thus, the adoption of various organic and inorganic strategies by the key market players is expected to provide opportunities for the coagulation market growth during the forecast period.

South & Central America Coagulation Market Overview

The South & Central America coagulation market is segmented into Brazil, Argentina, and the Rest of South & Central America. The factors that are likely to contribute to the market growth in this region include government initiatives to expand the healthcare infrastructure and a surge in the population with various chronic diseases such as liver diseases and hemophilia.

Chile, Colombia, Peru, Cuba, Venezuela, and Bolivia are among the major countries in the Rest of South & Central America. The countries are strengthening their healthcare infrastructure by allowing new market participants to enter the market. Furthermore, governments of these countries are showing interest and spending significantly on upgrading their healthcare services, which has triggered the number of health facilities in these countries. Moreover, a rise in the geriatric population, coupled with the burgeoning prevalence of blood disorders, cardiovascular diseases, liver diseases, etc., highlights the importance of precise blood component analysis, which fuels the growth of the coagulation market in the Rest of South & Central America.

South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Coagulation Market Segmentation

The South & Central America coagulation market is segmented based on disease indication, type, offering, technology, end user, and country.

Based on disease indication, the South & Central America coagulation market is segmented into vitamin k deficiency, liver disease, disseminated intravascular coagulation and pulmonary embolism, development of circulating anticoagulants, hemophilia, von willebrand's disease, and others. The liver disease segment held the largest South & Central America coagulation market share in 2022.

Based on type, the South & Central America coagulation market is bifurcated into clinical laboratory analysers and point-of-care testing analyzers. The clinical laboratory analysers segment held a larger South & Central America coagulation market share in 2022. Clinical laboratory analysers segment is further subsegmented into controls & calibrators, assays & reagents, instruments/systems, coagulation factors, and others.

In terms of offering, the South & Central America coagulation market is bifurcated into diagnosis and treatment. The diagnosis segment held a larger South & Central America coagulation market share in 2022. Diagnosis segment is further subsegmented into prothrombin time testing, fibrinogen testing, activated clotting time testing, activated partial thromboplastin time testing, d-dimmer testing, platelets function testing, and others. Treatment segment is further subsegmented into anti-fibrinolytic drugs, birth control pills, desmopressin & immunosuppressive medicines, vitamin k supplements, blood thinners, thrombin inhibitors or thrombolytics, replacement therapy, catheter-assisted thrombus removal, and others.

By technology, the South & Central America coagulation market is segmented into optical technology, mechanical technology, electrochemical technology, and others. The optical technology segment held the largest South & Central America coagulation market share in 2022.

By end user, the South & Central America coagulation market is segmented into clinical laboratories, hospitals, and others. The hospitals segment held the largest South & Central America coagulation market share in 2022.

Based on country, the South & Central America coagulation market is categorized into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America coagulation market in 2022.

F. Hoffmann-La Roche Ltd; Genrui Biotech Co., Ltd.; Horiba Ltd; ImproGen Diagnostik Kimya San & Tic Ltd.Sti.; Siemens Healthineers AG; Sysmex Corp; and Transasia Bio-Medicals Ltd are some of the leading companies operating in the South & Central America coagulation market.

Product Code: BMIRE00029858

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South & Central America Coagulation Market - Key Industry Dynamics

  • 4.1 Key Market Drivers:
    • 4.1.1 Increasing Prevalence of Blood Disorders
    • 4.1.2 Rising Prevalence of Cardiovascular Diseases
  • 4.2 Market Restraints
    • 4.2.1 High Costs Associated with Coagulation Analyzers
  • 4.3 Market Opportunities
    • 4.3.1 Growing Organic and Inorganic Strategies by Key Market Players
  • 4.4 Future Trends
    • 4.4.1 Development of Point-of-Care (POC) Coagulation Analyzers
  • 4.5 Impact Analysis

5. Coagulation Market - South & Central America Market Analysis

  • 5.1 South & Central America Coagulation Market Revenue (US$ million), 2022 - 2030

6. South & Central America Coagulation Market - Revenue and Forecast to 2030 - by Disease Indication

  • 6.1 Overview
  • 6.2 South & Central America Coagulation Market Revenue Share, by Disease Indication 2022 & 2030 (%)
  • 6.3 Vitamin K Deficiency
    • 6.3.1 Overview
    • 6.3.2 Vitamin K Deficiency: South & Central America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Liver Disease
    • 6.4.1 Overview
    • 6.4.2 Liver Disease: South & Central America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Disseminated Intravascular Coagulation and Pulmonary Embolism
    • 6.5.1 Overview
    • 6.5.2 Disseminated Intravascular Coagulation and Pulmonary Embolism: South & Central America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.6 Development of Circulating Anticoagulant
    • 6.6.1 Overview
    • 6.6.2 Development of Circulating Anticoagulant: South & Central America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.7 Hemophilia
    • 6.7.1 Overview
    • 6.7.2 Hemophilia: South & Central America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.8 Von Willebrand's Disease
    • 6.8.1 Overview
    • 6.8.2 Von Willebrand's Disease: South & Central America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.9 Others
    • 6.9.1 Overview
    • 6.9.2 Others: South & Central America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

7. South & Central America Coagulation Market - Revenue and Forecast to 2030 - by Type

  • 7.1 Overview
  • 7.2 South & Central America Coagulation Market Revenue Share, by Type 2022 & 2030 (%)
  • 7.3 Clinical Laboratory Analyzers
    • 7.3.1 Overview
    • 7.3.2 Clinical Laboratory Analyzers: South & Central America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.1 South & Central America Coagulation Market, by Clinical Laboratory Analyzers
  • 7.4 Point-of-Care Testing Analyzers
    • 7.4.1 Overview
    • 7.4.2 Point-of-Care Testing Analyzers: South & Central America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Coagulation Market - Revenue and Forecast to 2030 - by Offering

  • 8.1 Overview
  • 8.2 South & Central America Coagulation Market Revenue Share, by Offering 2022 & 2030 (%)
  • 8.3 Diagnosis
    • 8.3.1 Overview
    • 8.3.2 Diagnosis: South & Central America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.2.1 South & Central America Coagulation Market, by Diagnosis
  • 8.4 Treatment
    • 8.4.1 Overview
    • 8.4.2 Treatment: South & Central America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.4.2.1 South & Central America Coagulation Market, by Treatment

9. South & Central America Coagulation Market - Revenue and Forecast to 2030 - by Technology

  • 9.1 Overview
  • 9.2 South & Central America Coagulation Market Revenue Share, by Technology 2022 & 2030 (%)
  • 9.3 Optical Technology
    • 9.3.1 Overview
    • 9.3.2 Optical Technology: South & Central America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Mechanical Technology
    • 9.4.1 Overview
    • 9.4.2 Mechanical Technology: South & Central America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Electrochemical Technology
    • 9.5.1 Overview
    • 9.5.2 Electrochemical Technology: South & Central America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: South & Central America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Coagulation Market - Revenue and Forecast to 2030 - by End User

  • 10.1 Overview
  • 10.2 South & Central America Coagulation Market Revenue Share, by End User 2022 & 2030 (%)
  • 10.3 Clinical Laboratories
    • 10.3.1 Overview
    • 10.3.2 Clinical Laboratories: South & Central America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Hospitals
    • 10.4.1 Overview
    • 10.4.2 Hospitals: South & Central America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Others
    • 10.5.1 Overview
    • 10.5.2 Others: South & Central America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

11. South & Central America Coagulation Market - Country Analysis

  • 11.1 South & Central America Coagulation Market, Revenue and Forecast to 2030
    • 11.1.1 South & Central America Coagulation Market by Country
      • 11.1.1.1 Brazil
        • 11.1.1.1.1 Overview
        • 11.1.1.1.2 Brazil Coagulation Market Revenue and Forecast to 2030 (US$ million)
        • 11.1.1.1.3 Brazil Coagulation Market, by Disease Indication
        • 11.1.1.1.4 Brazil Coagulation Market, by Type
        • 11.1.1.1.4.1 Brazil Coagulation Market, by Clinical Laboratory Analyzer
        • 11.1.1.1.5 Brazil Coagulation Market, by Offering
        • 11.1.1.1.5.1 Brazil Coagulation Market, by Diagnosis
        • 11.1.1.1.5.2 Brazil Coagulation Market, by Treatment
        • 11.1.1.1.6 Brazil Coagulation Market, by Technology
        • 11.1.1.1.7 Brazil Coagulation Market, by End User
      • 11.1.1.2 Argentina
        • 11.1.1.2.1 Overview
        • 11.1.1.2.2 Argentina Coagulation Market Revenue and Forecast to 2030 (US$ million)
        • 11.1.1.2.3 Argentina Coagulation Market, by Disease Indication
        • 11.1.1.2.4 Argentina Coagulation Market, by Type
        • 11.1.1.2.4.1 Argentina Coagulation Market, by Clinical Laboratory Analyzer
        • 11.1.1.2.5 Argentina Coagulation Market, by Offering
        • 11.1.1.2.5.1 Argentina Coagulation Market, by Diagnosis
        • 11.1.1.2.5.2 Argentina Coagulation Market, by Treatment
        • 11.1.1.2.6 Argentina Coagulation Market, by Technology
        • 11.1.1.2.7 Argentina Coagulation Market, by End User
      • 11.1.1.3 Rest of South & Central America
        • 11.1.1.3.1 Rest of South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million)
        • 11.1.1.3.2 Rest of South & Central America Coagulation Market, by Disease Indication
        • 11.1.1.3.3 Rest of South & Central America Coagulation Market, by Type
        • 11.1.1.3.3.1 Rest of South & Central America Coagulation Market, by Clinical Laboratory Analyzer
        • 11.1.1.3.4 Rest of South & Central America Coagulation Market, by Offering
        • 11.1.1.3.4.1 Rest of South & Central America Coagulation Market, by Diagnosis
        • 11.1.1.3.4.2 Rest of South & Central America Coagulation Market, by Treatment
        • 11.1.1.3.5 Rest of South & Central America Coagulation Market, by Technology
        • 11.1.1.3.6 Rest of South & Central America Coagulation Market, by End User

12. Coagulation Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in the Coagulation Market
  • 12.3 Inorganic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Organic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Siemens Healthineers AG
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 ImproGen Diagnostik Kimya San. & Tic. Ltd.Sti.
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Sysmex Corp
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 F. Hoffmann-La Roche Ltd
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Genrui Biotech Co., Ltd.
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Transasia Bio-Medicals Ltd
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Horiba Ltd.
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments

14. Appendix

  • 14.1 About Us
  • 14.2 Glossary of Terms
Product Code: BMIRE00029858

List Of Tables

  • Table 1. South & Central America Coagulation Market Segmentation
  • Table 2. South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
  • Table 3. South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
  • Table 4. South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
  • Table 5. Optical Technologies and Their Applications
  • Table 6. Mechanical Technologies and Their Applications
  • Table 7. Brazil Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
  • Table 8. Brazil Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
  • Table 9. Brazil Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
  • Table 10. Brazil Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
  • Table 11. Brazil Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
  • Table 12. Brazil Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
  • Table 13. Brazil Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
  • Table 14. Brazil Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
  • Table 15. Argentina Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
  • Table 16. Argentina Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
  • Table 17. Argentina Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
  • Table 18. Argentina Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
  • Table 19. Argentina Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
  • Table 20. Argentina Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
  • Table 21. Argentina Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
  • Table 22. Argentina Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
  • Table 23. Rest of South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
  • Table 24. Rest of South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
  • Table 25. Rest of South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
  • Table 26. Rest of South & Central America Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
  • Table 27. Rest of South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
  • Table 28. Rest of South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
  • Table 29. Rest of South & Central America Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
  • Table 30. Rest of South & Central America Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
  • Table 31. Recent Inorganic Growth Strategies in the Coagulation Market
  • Table 32. Recent Organic Growth Strategies in the Coagulation Market
  • Table 33. Glossary of Terms, Coagulation Market

List Of Figures

  • Figure 1. South & Central America Coagulation Market Segmentation, By Country
  • Figure 2. South & Central America Coagulation Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. South & Central America Coagulation Market Revenue (US$ million), 2020 - 2030
  • Figure 5. South & Central America Coagulation Market Revenue Share, by Disease Indication 2022 & 2030 (%)
  • Figure 6. Vitamin K Deficiency: South & Central America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Liver Disease: South & Central America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Disseminated Intravascular Coagulation and Pulmonary Embolism: South & Central America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Development of Circulating Anticoagulant: South & Central America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Hemophilia: South & Central America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Von Willebrand's Disease: South & Central America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Others: South & Central America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. South & Central America Coagulation Market Revenue Share, by Type 2022 & 2030 (%)
  • Figure 14. Clinical Laboratory Analyzers: South & Central America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Point-of-Care Testing Analyzers: South & Central America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. South & Central America Coagulation Market Revenue Share, by Offering 2022 & 2030 (%)
  • Figure 17. Diagnosis: South & Central America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Treatment: South & Central America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. South & Central America Coagulation Market Revenue Share, by Technology 2022 & 2030 (%)
  • Figure 20. Optical Technology: South & Central America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Mechanical Technology: South & Central America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Electrochemical Technology: South & Central America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Others: South & Central America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. South & Central America Coagulation Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 25. Clinical Laboratories: South & Central America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Hospitals: South & Central America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Others: South & Central America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Coagulation Market, By Country, 2022 (US$ million)
  • Figure 29. South & Central America Coagulation Market, By Key Countries, 2022 and 2030 (%)
  • Figure 30. Brazil Coagulation Market Revenue and Forecast to 2030 (US$ million)
  • Figure 31. Argentina Coagulation Market Revenue and Forecast to 2030 (US$ million)
  • Figure 32. Rest of South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million)
  • Figure 33. Growth Strategies in the Coagulation Market
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!